Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyglucosan body disease.

M S Cafferty1, R E Lovelace, A P Hays

  • 1Neurology Division, St. Luke's-Roosevelt Hospital, New York, NY 10025.

Muscle & Nerve
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALS Untangled No. 20: the Deanna protocol.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2013
Same author

HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2011
Same author

Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Neurology·2009
Same author

Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.

Neurology·2009
Same author

Transcranial magnetic stimulation in ALS: utility of central motor conduction tests.

Neurology·2009
Same author

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

Neurology·2007

Adult polyglucosan disease, a rare neurological disorder, presents with peripheral neuropathy, upper motor neuron signs, and often dementia and sphincter issues. Diagnosis requires clinical correlation alongside polyglucosan body identification in biopsies, as the specific enzyme defect remains unknown.

Area of Science:

  • Neurology
  • Genetics

Background:

  • Adult polyglucosan disease (APGD) is a rare genetic disorder characterized by the accumulation of polyglucosan bodies in various tissues.
  • Previous reports describe a limited number of cases, highlighting key clinical manifestations.

Observation:

  • This report details two new cases of APGD exhibiting prominent peripheral neuropathy, upper motor neuron signs, and cognitive impairment.
  • Sphincter dysfunction was noted in a significant majority of previously reported cases and is a key clinical feature.

Findings:

  • Electrophysiological studies confirmed axonal neuropathy, with abnormal somatosensory evoked potentials in one patient.
  • Sural nerve biopsy revealed characteristic clusters of polyglucosan bodies, crucial for diagnosis when combined with clinical presentation.
  • Normal branching enzyme activity in muscle extracts suggests the underlying enzymatic defect is not yet identified.

Related Experiment Videos

Implications:

  • The findings underscore the importance of integrating clinical features with histopathological evidence for accurate APGD diagnosis.
  • Further research is needed to elucidate the specific enzyme deficiency responsible for APGD.
  • Understanding the pathophysiology of APGD can guide future therapeutic strategies for this debilitating neurological condition.